Stocks · News reference

HC Wainwright & Co. Maintains Buy on EyePoint, Lowers Price Target to $27

Aug 6, 2026, 10:54 AMBenzinga Newsdesk

HC Wainwright & Co. analyst Yi Chen maintains EyePoint (NASDAQ:EYPT) with a Buy and lowers the price target from $30 to $27.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaAug 25, 2026, 2:03 PMAvi Kapoor
Nayax, Immatics, Moderna, Marvell Technology And Other Big Stocks Moving Higher On Tuesday
Nasdaq: NYAX rose 13.9% on Tuesday after announcing acquisition of IPS Group Inc. for $350 million. Other big gainers include CAPR, RZLV, CRML, and MAIR.
Read original at benzinga
ABCL CAPR CDLR CRML EIKN
BenzingaAug 19, 2026, 4:26 PMBenzinga Newsdesk
EyePoint shares are trading higher after a Form 4 filing indicated that a company Director bought 10,600 shares at an average price of $4.93 per share.
Read original at benzinga
EYPT
BenzingaAug 18, 2026, 12:39 PMBenzinga Newsdesk
RBC Capital Downgrades EyePoint to Sector Perform, Lowers Price Target to $5
RBC Capital analyst Lisa Walter downgrades EyePoint (NASDAQ:EYPT) from Outperform to Sector Perform and lowers the price target from $37 to $5.
Read original at benzinga
EYPT
BenzingaAug 18, 2026, 12:03 PMBenzinga Newsdesk
Chardan Capital Downgrades EyePoint to Neutral, Lowers Price Target to $5
Chardan Capital analyst Andreas Argyrides downgrades EyePoint (NASDAQ:EYPT) from Buy to Neutral and lowers the price target from $65 to $5.
Read original at benzinga
EYPT